Shenzhen Noposion Crop Science Co Ltd

The company maintains a debt-to-equity ratio of 1.28, indicating a moderate reliance on debt financing. Its liquidity position is assessed as medium, with a current ratio of 0.75, suggesting potential short-term liquidity constraints. Free cash flow is negative at -410.69 million CNY, reflecting capital expenditure outpacing operating cash flow. Return on equity is 15.63%, and return on assets is 5.48%, both above the industry median for Agricultural Chemicals, indicating strong profitability relative to its asset base.

Profitability metrics show a gross profit of 2.15 billion CNY and operating income of 667.41 million CNY, translating to a gross margin of 37.14% and operating margin of 11.54%. These figures are in line with the industry's preferred metrics for Agricultural Chemicals, which emphasize margin stability and cost control. The company's net income of 650.42 million CNY represents a net margin of 11.24%, which is robust compared to the sector median.

The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification in the provided data. This lack of segment or geographic diversification introduces concentration risk, as the company's performance is tied to a single product line and potentially a single market.

Looking ahead, the company is projected to maintain a stable revenue trajectory, with no significant growth or decline expected in the next fiscal year. Capital expenditure of -1.24 billion CNY indicates ongoing investment in infrastructure or production capacity, which may support future growth. However, the negative free cash flow suggests that these investments are currently funded by operating cash flow rather than excess liquidity.

The company's risk profile is characterized by medium liquidity risk and low dilution risk. The negative net cash position after subtracting total debt raises concerns about short-term liquidity. However, the low dilution risk indicates that the company is not expected to issue additional shares in the near term, preserving shareholder value. The governance pillar score of 32.19 suggests room for improvement in corporate governance practices.

Recent filings and transcripts do not indicate any material events or strategic shifts in the company's operations. Analysts have provided a consistent price target of 13.80 CNY, with no variance between mean, median, high, or low estimates. This consensus suggests a stable outlook for the company's stock price in the near term.

Shenzhen Noposin Crop Science Co Ltd (002215.SZ) has undergone a significant update to its corporate taxonomy, now formally classified under the "Chemicals" activity and "Basic Materials" economic sector. This reclassification represents a medium-severity change in the company's profile, establishing a clearer framework for understanding its operational focus within the broader industrial landscape. Alongside the sectoral update, the company's risk assessment metrics have been initialized. The dilution risk is now rated as "low," indicating a stable capital structure with minimal immediate threat of share value erosion from new issuances. This assessment provides investors with a baseline for evaluating the security of their equity position. Conversely, the liquidity risk has been assessed at a "medium" level. This designation suggests that while the company maintains operational fluidity, there may be moderate constraints or volatility in its ability to meet short-term obligations or trade volume expectations compared to peers with lower liquidity risk profiles. These updates collectively refine the analytical view of Shenzhen Noposin Crop Science, moving from an undefined state to a structured profile with specific sectoral and risk attributes. The combination of a low dilution risk and medium liquidity risk, set against a Basic Materials classification, offers a more precise context for evaluating the company's financial health and market positioning.